Please login to the form below

Not currently logged in
Email:
Password:

Valtrex

This page shows the latest Valtrex news and features for those working in and with pharma, biotech and healthcare.

GSK holds on to older products

GSK holds on to older products

£185m. Other products in GSK's established portfolio with declining sales include antidepressant Seroxat/Paxil (paroxetine) and antiviral drug Valtrex (valacyclovir), both of which had a double digit fall in revenues

Latest news

  • GSK back in profit for Q2

    In its report, GSK offered an 'underlying' sales performance, which excluded these products, as well as herpes treatment Valtrex (valacyclovir).

  • GSK sales fall for first quarter of 2011

    The company said the decrease in sales was mainly due to a fall in demand for its pandemic flu products; generic competition for herpes treatment Valtrex (valaciclovir); and increased restrictions in

  • Avandia damages GSK Q3 results

    Herpes treatment, Valtrex (valacyclovir fydrochloride) also saw a significant fall in sales, with generic competition in Europe and the US leading to a 75 per cent loss. ... Speaking on the company's performance, Andrew Witty, CEO, GSK, said: "Comparison

  • Q2 net loss for GSK

    Sales in the US were impacted by individual factors and adverse prior year comparisons, such as an acceleration of generic competition to Valtrex (valacyclovir), the temporary suspension of Rotarix (rotavirus vaccine),

  • S&H appoints director of account services

    John left S&H for a short stint at DraftFCB, where he was the lead account person on Cialis (tadalafil) and Valtrex (valacyclovir).

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics